• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEART VALVES SANTA ANA MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEART VALVES SANTA ANA MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 305U
Device Problem Hole In Material (1293)
Patient Problem No Code Available (3191)
Event Date 02/20/2017
Event Type  Injury  
Manufacturer Narrative
The patient information and the device serial number have not been reported.Without more information, the device manufacturing and expiration date may not be obtained.Additional information has been requested, but no additional information has been received.The device has not been received for analysis.Without the return of the product, no definitive conclusion can be made regarding the clinical observation.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that this bioprosthetic valve was explanted due to clot formation on the ventricular side and a leaflet hole.Prior to the replacement procedure, the patient was symptomatic.The device implant duration was not reported.No other adverse patient effects were reported.
 
Manufacturer Narrative
Medtronic received additional information that this device was implanted for one year, eight months before being explanted.
 
Manufacturer Narrative
Product analysis: the device was received at medtronic in a clear 10% formalin solution in a small specimen container enclosed in a small biohazard bag.A visual examination of the returned device was performed upon receipt.The stent posts appeared deflected.Stent post measured lr= 12°, rnc= -2°, ncl= 9°.All leaflets appeared slightly stiff but flexible except where host tissue extended on the inflow and/or outflow of the non-coronary cusp.Tears or abrasions through the free margin and lunula of all cusps appeared to be associated with contact with the bias cloth or possible long suture tails, or a combination of the two.Tiny tears in the left right commissure appeared to have occurred during explant.The right non-coronary and non-coronary left commissures appeared intact.Glistening off-white pannus remained attached to the sewing ring on the inflow adjacent to the right and non-coronary cusps, extending to the tissue and base stitching, to the right non-coronary and non-coronary left inferior coaptive areas and 1 to 3 mm onto all cusps showing a reduced inflow orifice area.Pannus on the outflow lines the sewing ring on the outflow, extending partially onto the left right and right non-coronary commissures.An unknown amount of pannus appeared to have been removed on the inflow and outflow during explant.Radiography showed trace mineralization in the host tissue along the outflow rail adjacent to the non-coronary and left cusps.The device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Conclusion: pannus overgrowth is associated with surgical valve replacement due to patient interaction and healing response with the surgical valve.The pannus overgrowth on the inflow appears to have extended several millimeters out onto the leaflet which would have significantly impaired the leaflet mobility.The impairment of leaflet mobility may have led to the thrombus formation on the outflow of the valve.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
HEART VALVES SANTA ANA
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
HEART VALVES SANTA ANA
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6401361
MDR Text Key69839663
Report Number2025587-2017-00396
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 06/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/08/2019
Device Model Number305U
Device Catalogue Number305U223
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/29/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/12/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/24/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-